Total Funding
75
16
Total FundingVenture - Series Unknown raised
Growth Score 75 in past quarter
-5 pts
Heat Score 16 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
803569
Antria is a clinical research firm developing regenerative medicine and cellular therapies for the treatment of diverse diseases.
- Sharon Barto: Vice President
- Sarah Bryan: Chief Operating Officer
About the Company
Antria, Inc. operates as a clinical research organization that specializes in the development of regenerative medicine and cellular therapies for the treatment of diverse diseases. The company also provides its services to biotechnology companies and the research industry. It applies autologous adult stem cells and platelet rich plasma technologies
to discern, detect, and prevent illnesses in a myriad of medical specialties. The company’s research pipeline spans multiple medical disciplines and specialties, including cosmetic and reconstructive surgery, neurology, cardiology, orthopedics, and internal medicine; and chronic and non healing wounds, breast cancer and augmentation, multiple scle...
